Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.48
Delayed Data
As of Apr 17
 -0.07 / -4.52%
Today’s Change
0.97
Today|||52-Week Range
2.02
-21.69%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.55
Today’s open1.54
Day’s range1.46 - 1.55
Volume649,243
Average volume (3 months)538,463
Market cap$222.5M
Dividend yield--
Data as of 4:04pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+47.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.09-1.76%
GALEGalena Biopharma Inc-0.03-2.10%
XENEXenon Pharmaceutical...-1.14-6.71%
MDGNMedgenics Inc+0.13+1.44%
Data as of 4:01pm ET, 04/17/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers